The incidence rate in the GLP‐1 RA arm for all adiposity‐related cancers was 8.0 per 1000 person‐years (vs. 8.7 in the DPP4i arm), and 7.1 (vs. 7.6 in the DPP4i arm) for traditional adiposity‐related cancers. Here, GLP1R is linked to cancer.